LYEONS is a Cambridge-based UK neurotechnology startup founded in 2024 that builds non-invasive, body-first devices for nervous system regulation and everyday brain health. Its first product, the LYEONS Heart, is a portable device that uses gentle, heartbeat-like audio-tactile sensory stimulation to help people manage stress, anxiety, sleep difficulties and sensory overload. Led by founder Lucy Jung, the company is running beta user cohorts while building clinical evidence alongside researchers, clinicians and partners in the Cambridge ecosystem.
1
Round
1
Industry
5
Tags
Sep 11, 2026
Latest raise
Funding activity · 1 round
Sep 11, 2026
GBP 129,000
Seed
Lyeons Raises £129K Seed Round Lyeons, a Cambridge based neurotechnology startup, has raised £129,000 in seed funding. The round was announced on September 11,…
Read articlePricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
